YBL-17027-94370
3 vaccinations
7 coded responses
30 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 554 / MN
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Dose 1 — Pfizer-BioNTech
-
2020-12-31
Registered in v-safe
-
2020-12-31
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Injection site erythema, Injection site pain, Injection site urticaria, Pain — Feeling: Good · Site: Pain, RednessFree text: Feels almost like a small welt/bruising under the skin at the injection site, tender when touched, about a nickel sized area of redness at injection site, mildly sore arm on movemebtMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Urticaria — Feeling: Good · Site: Pain, RednessFree text: Still have a welt/bruise like underneath skin at the injection site, less tender when touchedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-02
Survey response — days 1–6 daily, dose 1MedDRA: Injection site erythema, Injection site mass, Injection site pain — Feeling: Good · Site: Pain, RednessFree text: Continue to have redness and a lump underneath skin at injection site, this is about a quarter sized. Less tenderness when site is touched.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-03
Survey response — days 1–6 daily, dose 1MedDRA: Injection site mass, Injection site pain — Feeling: Good · Site: Pain, SwellingFree text: Quarter sized lump under the injection site, mild tenderness when injection site is touchedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-04
Survey response — days 1–6 daily, dose 1MedDRA: Injection site mass — Feeling: GoodFree text: Lump under skin at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-06
- 2021-01-13
-
2021-01-19
Dose 2 — Pfizer-BioNTech
- 2021-02-04
- 2021-02-09
- 2021-02-16
-
2021-02-23
Survey response — day 35, dose 2MedDRA: Gastrooesophageal reflux disease — Feeling: GoodFree text: Acid reflux not related to vaccine/COVIDMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-02
- 2021-04-20
- 2021-07-20
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
- 2021-12-30
- 2022-03-31
-
2022-09-30
Survey response — 12 months, dose 3MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVIDMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-19 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Feels almost like a small welt/bruising under the skin at the injection site, tender when touched, about a nickel sized area of redness at injection site, mildly sore arm on movemebt
Systemic reaction (other): Still have a welt/bruise like underneath skin at the injection site, less tender when touched
Systemic reaction (other): Continue to have redness and a lump underneath skin at injection site, this is about a quarter sized. Less tenderness when site is touched.
Systemic reaction (other): Quarter sized lump under the injection site, mild tenderness when injection site is touched
Systemic reaction (other): Lump under skin at injection site
Release 4 — day 35, dose 2
Symptoms: Acid reflux not related to vaccine/COVID
Release 12 — 12 months, dose 3
Symptoms: COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site erythema | ✓ | ✓ | ✓ |
| SRO | Injection site mass | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site urticaria | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ○ | ○ | ○ |
| SRO | Urticaria | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release